These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16468244)

  • 1. [Abuse of buprenorphine becomes a problem of the Czech Republic].
    Nespor K; Csémy L
    Cas Lek Cesk; 2006; 145(1):59-60. PubMed ID: 16468244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.
    Alho H; Sinclair D; Vuori E; Holopainen A
    Drug Alcohol Depend; 2007 Apr; 88(1):75-8. PubMed ID: 17055191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic.
    Mravčík V; Janíková B; Drbohlavová B; Popov P; Pirona A
    Harm Reduct J; 2018 Dec; 15(1):60. PubMed ID: 30514306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.
    Cunningham CO; Sohler NL; McCoy K; Kunins HV
    Fam Med; 2006 May; 38(5):336-40. PubMed ID: 16673195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in substance abuse by teenagers in the Czech Republic.
    Seblova J; Polanecky V; Sejda J; Studnickova B
    J Emerg Med; 2005 Jan; 28(1):95-100. PubMed ID: 15657016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse of buprenorphine in the United States: 2003-2005.
    Smith MY; Bailey JE; Woody GE; Kleber HD
    J Addict Dis; 2007; 26(3):107-11. PubMed ID: 18018814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone).
    Welsh C; Sherman SG; Tobin KE
    Addiction; 2008 Jul; 103(7):1226-8. PubMed ID: 18554353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
    Lavie E; Fatséas M; Denis C; Auriacombe M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suboxone (buprenorphine/naloxone) toxicity in pediatric patients: a case report.
    Schwarz KA; Cantrell FL; Vohra RB; Clark RF
    Pediatr Emerg Care; 2007 Sep; 23(9):651-2. PubMed ID: 17876257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Information System in the Czech Republic.
    Sejda J; Studnicková B; Polanecký V
    Cent Eur J Public Health; 2001 Nov; 9(4):179-82. PubMed ID: 11787244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using buprenorphine short-term taper to facilitate early treatment engagement.
    Brigham GS; Amass L; Winhusen T; Harrer JM; Pelt A
    J Subst Abuse Treat; 2007 Jun; 32(4):349-56. PubMed ID: 17481458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing opioid addiction with buprenorphine.
    Donaher PA; Welsh C
    Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network].
    Modelon H; Frauger E; Laurenceau D; Thirion X; Mallaret M; Micallef J;
    Therapie; 2007; 62(4):337-46. PubMed ID: 17983559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Summary of illegal drug use in the Czech Republic].
    Miovský M; Miovská L; Mravcík V
    Cas Lek Cesk; 2004; 143(11):723-30. PubMed ID: 15628564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine therapy: an increasing challenge in oral and maxillofacial surgery.
    Wasson M; Beirne OR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):142-6. PubMed ID: 23849373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The drug-use situation in the Czech Republic.
    Tyrlik M; Zuda T; Bem P; Power R
    Bull Narc; 1996; 48(1-2):89-98. PubMed ID: 9839038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of opioid formulations with limited diversion and abuse potential.
    Fudala PJ; Johnson RE
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S40-7. PubMed ID: 16564141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
    Correia CJ; Walsh SL; Bigelow GE; Strain EC
    Psychopharmacology (Berl); 2006 Dec; 189(3):297-306. PubMed ID: 17013637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.